证券之星消息,红日药业(300026)04月16日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,你好!KB二期临床己经结束,三期临床什么时候开始?二期临床结果怎样,请回答,谢谢红日药业回复:您好,KB项目目前已完成Ⅱb临床研究,相关工作均在正常开展。研发后续进展情况还请关注公司公告。感谢您的关注!为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。
证券之星消息,红日药业(300026)04月16日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,你好!KB二期临床己经结束,三期临床什么时候开始?二期临床结果怎样,请回答,谢谢红日药业回复:您好,KB项目目前已完成Ⅱb临床研究,相关工作均在正常开展。研发后续进展情况还请关注公司公告。感谢您的关注!为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.